EMA regular press briefing on COVID-19
The European Medicines Agency (EMA) holds fortnightly regular press briefings to provide an update on EMA’s COVID-19 activities.
- Marco Cavaleri (Head of Biological Health Threats and Vaccines Strategy)
- Fergus Sweeney (Head of Clinical Studies and Manufacturing Task Force)
- Georgy Genov (Head of Pharmacovigilance)
The press briefing will be moderated by Marie-Agnes Heine (Head of Communication).
The press briefing will be held in English. No translations will be provided.
The press briefing can be followed live below via EMA's YouTube channel or on EMA’s LinkedIn page.